Refractory Lymphoblastic Lymphoma: Clinical Trials

2 trials for Refractory Lymphoblastic Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 terminated. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 1, Terminated 1
Phase 11Terminated 1

Follow Refractory Lymphoblastic Lymphoma: new trials by email Literature Review of Refractory Lymphoblastic Lymphoma trials Research Report on Refractory Lymphoblastic Lymphoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Cyclophosphamide, Cytarabine, Dexamethasone - Recurrent Adult Lymphoblastic Lymphoma, Recurrent B Acute Lymphoblastic Leukemia
Phase 1 / Phase 2TerminatedM.D. Anderson Cancer Center42022-02-172025-08-11
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
Bortezomib, Clofarabine, Cyclophosphamide - Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma
Phase 2RecruitingM.D. Anderson Cancer Center422017-08-092026-08-10

Narrower conditions

Burkitt Lymphoma (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

DNA Virus Infections (2)  ·  Epstein-Barr Virus Infections (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Herpesviridae Infections (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Infections (2)  ·  Leukemia (2)  ·  Leukemia, Lymphoid (2)  ·  Lymphatic Diseases (2)  ·  Lymphoma (2)  ·  Lymphoma, B-Cell (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Lymphoproliferative Disorders (2)

Interventions

CT-P10 (2)  ·  Calcium Dobesilate (2)  ·  Cyclophosphamide (2)  ·  Dexamethasone (2)  ·  Rituximab (2)  ·  Vincristine (2)  ·  auricularum (2)  ·  dexamethasone 21-phosphate (2)  ·  dexamethasone acetate (2)  ·  pegfilgrastim (2)  ·  Bortezomib (1)  ·  Clofarabine (1)  ·  Cytarabine (1)  ·  Etoposide (1)  ·  Filgrastim (1)

Sponsors

M.D. Anderson Cancer Center (2)

Countries

United States (2)

Top investigators

Maro Ohanian (1)  ·  Nicholas Short, MD (1)